What the business is, and whether it's a good one at a fair price.
Operates a generic-medicine retail pharmacy chain primarily under the Davaindia brand, with 2,579 stores across 23 states at end of FY26, after adding 997 new stores during the year (804 COCO + 193 FOFO). Davaindia contributed 77% of consolidated revenue in FY26. The chain runs two store formats: Company Owned Company Operated (COCO) and Franchise Owned Franchise Operated (FOFO). COCO gross margins exceed 70% and overall gross margin reached 60.28% in FY26. The network expanded further to 2,825 stores by end of Q1FY27 (1,855 COCO + 970 FOFO). Same-store growth has been 35-40% for stores aged 24+ months and 55-60% for stores aged 12-24 months. Through subsidiaries, additional retail pharmacy formats are being developed: Ugo Generic (KMHP Ventures, targeting B2B and B2C models) and SKIA (Curexis Ventures). Management has guided to 500-700 new Davaindia stores in FY27, with a long-term target of 5,000+ stores by FY29. Employee cost is the largest expense at 33.1% of revenue.
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from ZOTA HEALTH CARE LIMITED's filed financials and exchange disclosures
ZOTA HEALTH CARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE, trading under the symbol ZOTA.
No. Over the trailing twelve months ZOTA HEALTH CARE LIMITED reported a net loss of ₹104 Cr on revenue of ₹609 Cr.
Yes. The dividend yield is 0.08% at the current price.
Effectively yes. Debt stands at 0.04× equity.
On a typical session ZOTA HEALTH CARE LIMITED moves 1.37% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by ZOTA HEALTH CARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
